Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SOLIGENIX, INC. Director's Dealing 2025

Jun 20, 2025

35119_dirs_2025-06-20_a8af7274-b718-450d-b77b-60e31e2dc530.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SOLIGENIX, INC. (SNGX)
CIK: 0000812796
Period of Report: 2025-06-20

Reporting Person: Parks Diane L. (N/A)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-06-20 Stock Option (Right to Buy) $1.70 A 17647 Acquired 2035-06-20 Common Stock (17647) Direct

Footnotes

F1: The stock option vests ratably on each of September 20, 2025, December 20, 2025, March 20, 2026 and June 20, 2026.